How much dividend does AstraZeneca pay?
Over the past 12 months, AstraZeneca paid a dividend of 2.35 USD . This corresponds to a dividend yield of about 1.77 %. For the coming 12 months, AstraZeneca is expected to pay a dividend of 0.56 USD.
AstraZeneca Dividend 2025
AstraZeneca Dividend
2.34 USD
AstraZeneca Dividend yield
1.77 %
Ticker
AZN.L
ISIN
GB0009895292
WKN
886455
How much dividend does AstraZeneca 2025 pay?
According to the latest status from January 2025, AstraZeneca paid a total of 2.34 USD per share in dividends within the last 12 months. With the current AstraZeneca price of 132.7 USD, this corresponds to a dividend yield of 1.76 %. A dividend is paid 2 times per year.
| 1.77 % Dividend Yield | = |
|
Historical AstraZeneca Dividends
A dividend is paid 2 times per year. Last year, the payout months were March and September.
| Paydate | Dividend |
|---|---|
| 9/8/2024 | 0.78 |
| 3/22/2024 | 1.56 |
| 9/10/2023 | 0.72 |
| 3/23/2023 | 1.63 |
| 9/11/2022 | 0.76 |
| 3/24/2022 | 1.45 |
| 9/12/2021 | 0.65 |
| 3/25/2021 | 1.37 |
| 9/13/2020 | 0.7 |
| 3/27/2020 | 1.46 |
| 9/8/2019 | 0.72 |
| 3/28/2019 | 1.47 |
| 9/9/2018 | 0.68 |
| 3/15/2018 | 1.34 |
| 9/10/2017 | 0.69 |
| 3/16/2017 | 1.5 |
| 9/11/2016 | 0.69 |
| 3/18/2016 | 1.46 |
| 9/13/2015 | 0.64 |
| 3/19/2015 | 1.39 |
1
2
3
4
AstraZeneca dividend history and estimates GB0009895292 · 886455
In 2024, AstraZeneca paid a dividend amounting to 2.34 USD. Dividend means that AstraZeneca distributes a portion of its profits to its owners.
3 years
5 years
10 years
25 Years
Max
Dividend
Dividend (Estimate)
Details
Dividend
ⓘDividend Overview
The dividend per year chart for AstraZeneca provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.
Interpretation and Use
A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify AstraZeneca’s potential for long-term investment and income generation through dividends.
Investment Strategy
Incorporate the dividend data in evaluating AstraZeneca's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.
AstraZeneca Dividend History
| Date | AstraZeneca Dividend |
|---|---|
| 2029e | 0.6 undefined |
| 2028e | 0.7 undefined |
| 2027e | 0.54 undefined |
| 2026e | 0.56 undefined |
| 2025e | 1.01 undefined |
| 2024e | 0.05 undefined |
| 2023 | 2.35 undefined |
| 2022 | 2.22 undefined |
| 2021 | 2.02 undefined |
| 2020 | 2.16 undefined |
| 2019 | 2.19 undefined |
| 2018 | 2.02 undefined |
| 2017 | 2.19 undefined |
| 2016 | 2.14 undefined |
| 2015 | 2.03 undefined |
| 2014 | 1.89 undefined |
| 2013 | 3.11 undefined |
| 2012 | 3.17 undefined |
| 2011 | 3 undefined |
| 2010 | 2.68 undefined |
| 2009 | 2.32 undefined |
| 2008 | 2.11 undefined |
| 2007 | 1.94 undefined |
| 2006 | 1.57 undefined |
| 2005 | 1.14 undefined |
| 2004 | 0.93 undefined |
| Dividend | Dividend (Estimate) | |
|---|---|---|
| 2004 | 0.93 USD | 0 USD |
| 2005 | 1.14 USD | 0 USD |
| 2006 | 1.57 USD | 0 USD |
| 2007 | 1.94 USD | 0 USD |
| 2008 | 2.11 USD | 0 USD |
| 2009 | 2.32 USD | 0 USD |
| 2010 | 2.68 USD | 0 USD |
| 2011 | 3 USD | 0 USD |
| 2012 | 3.17 USD | 0 USD |
| 2013 | 3.11 USD | 0 USD |
| 2014 | 1.89 USD | 0 USD |
| 2015 | 2.03 USD | 0 USD |
| 2016 | 2.14 USD | 0 USD |
| 2017 | 2.19 USD | 0 USD |
| 2018 | 2.02 USD | 0 USD |
| 2019 | 2.19 USD | 0 USD |
| 2020 | 2.16 USD | 0 USD |
| 2021 | 2.02 USD | 0 USD |
| 2022 | 2.22 USD | 0 USD |
| 2023 | 2.35 USD | 0 USD |
| 2024e | 0 USD | 0.05 USD |
| 2025e | 0 USD | 1.01 USD |
| 2026e | 0 USD | 0.56 USD |
| 2027e | 0 USD | 0.54 USD |
| 2028e | 0 USD | 0.7 USD |
| 2029e | 0 USD | 0.6 USD |
Is the AstraZeneca Dividend Safe?
AstraZeneca has been increasing the dividend for 2 years.
Over the past 10 years, AstraZeneca has increased it by an annual -2.783 %.
Over a five-year period, the distribution increased by 3.038%.
Analysts expect a Dividend Cut of -85.139% for the current fiscal year.
AstraZeneca dividend payout ratio GB0009895292 · 886455
In 2024, AstraZeneca had a payout ratio of 1,201.55%. The payout ratio indicates the percentage of the company's profits that AstraZeneca distributes as dividends.
3 years
5 years
10 years
25 Years
Max
Payout ratio
Details
Payout ratio
ⓘWhat is Yearly Payout Ratio?
The yearly payout ratio for AstraZeneca represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.
How to Interpret the Data
A lower payout ratio for AstraZeneca could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.
Using the Data for Investments
Evaluate AstraZeneca's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.
AstraZeneca Payout Ratio History
| Date | AstraZeneca Payout ratio |
|---|---|
| 2029e | 937.3 % |
| 2028e | 888.82 % |
| 2027e | 967 % |
| 2026e | 956.09 % |
| 2025e | 743.36 % |
| 2024e | 1,201.55 % |
| 2023 | 923.35 % |
| 2022 | 105.19 % |
| 2021 | 2,576.12 % |
| 2020 | 88.74 % |
| 2019 | 213.13 % |
| 2018 | 118.76 % |
| 2017 | 92.84 % |
| 2016 | 77.52 % |
| 2015 | 90.8 % |
| 2014 | 193.53 % |
| 2013 | 152.51 % |
| 2012 | 63.59 % |
| 2011 | 41.1 % |
| 2010 | 48.08 % |
| 2009 | 44.74 % |
| 2008 | 50.26 % |
| 2007 | 52.13 % |
| 2006 | 40.69 % |
| 2005 | 39.14 % |
| 2004 | 42.56 % |
| Payout ratio | |
|---|---|
| 2004 | 42.56 % |
| 2005 | 39.14 % |
| 2006 | 40.69 % |
| 2007 | 52.13 % |
| 2008 | 50.26 % |
| 2009 | 44.74 % |
| 2010 | 48.08 % |
| 2011 | 41.1 % |
| 2012 | 63.59 % |
| 2013 | 152.51 % |
| 2014 | 193.53 % |
| 2015 | 90.8 % |
| 2016 | 77.52 % |
| 2017 | 92.84 % |
| 2018 | 118.76 % |
| 2019 | 213.13 % |
| 2020 | 88.74 % |
| 2021 | 2,576.12 % |
| 2022 | 105.19 % |
| 2023 | 923.35 % |
| 2024e | 1,201.55 % |
| 2025e | 743.36 % |
| 2026e | 956.09 % |
| 2027e | 967 % |
| 2028e | 888.82 % |
| 2029e | 937.3 % |
Dividend Details
Understanding AstraZeneca's Dividend Distributions
AstraZeneca’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Year-to-Year Comparison
Examining AstraZeneca's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Impact on Investments
AstraZeneca's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Interpreting Dividend Fluctuations
Changes in AstraZeneca’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
AstraZeneca Aktienanalyse
What does AstraZeneca do?
AstraZeneca PLC is a globally operating pharmaceutical company with its headquarters in England. The company was founded in 1999 through the merger of the Swedish company Astra AB and the British Zeneca Group PLC. Today, AstraZeneca employs more than 70,000 people and operates in over 100 countries. AstraZeneca specializes in the development, manufacturing, and marketing of pharmaceutical products. The company focuses primarily on oncology, cardiovascular and metabolic diseases, respiratory diseases, and autoimmune diseases. AstraZeneca is divided into various business segments. The oncology segment is a major focus of the company. Here, medications for various types of cancer are developed and manufactured. One particularly well-known product is the breast cancer medication Tamoxifen. In the cardiovascular and metabolic diseases segment, AstraZeneca offers various medications for heart and circulatory diseases as well as diabetes. One of the most well-known medications is Crestor, which is used to lower cholesterol levels. Another important area for AstraZeneca is respiratory diseases. Medications for the treatment of asthma and chronic obstructive pulmonary disease (COPD) are developed and manufactured here. The medication Pulmicort is particularly well-known among asthma patients. Finally, AstraZeneca is also active in the field of autoimmune diseases. Medications against lupus erythematosus and rheumatoid arthritis are developed and manufactured here. AstraZeneca strives to improve healthcare worldwide through research and development of new medications. The company works closely with universities and research institutions and invests billions of dollars annually in research and development. AstraZeneca also pursues a sustainable business strategy and emphasizes acting environmentally and socially responsibly. The company is committed to reducing CO2 emissions and minimizing waste production. Over the years, AstraZeneca has received numerous awards and prizes, including the Sunday Times Innovation Award of the Decade, the Fierce Biotech Award for the medication Tagrisso, and the Prix Galien USA Award for Crestor. AstraZeneca aims to develop innovative medications that improve the lives of patients and advance healthcare worldwide. The company believes in a sustainable business strategy and actively promotes environmental and social responsibility. AstraZeneca will remain an important player in the global pharmaceutical industry in the future. AstraZeneca is one of the most popular companies on Eulerpool.com.Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The AstraZeneca stock can be added to a savings plan with the following providers: Scalable Capital and Consorsbank
Frequently Asked Questions about AstraZeneca stock
What is the dividend yield of AstraZeneca?
The current dividend yield of AstraZeneca is 1.77 %.
When does AstraZeneca pay dividends?
AstraZeneca pays a quarterly dividend. This is distributed in the months of March, September, March, September.
How secure is the dividend of AstraZeneca?
AstraZeneca paid dividends every year for the past 26 years.
What is the dividend of AstraZeneca?
For the upcoming 12 months, dividends amounting to 0.56 USD are expected. This corresponds to a dividend yield of 0.42 %.
In which sector is AstraZeneca located?
AstraZeneca is assigned to the 'Health' sector.
Wann musste ich die Aktien von AstraZeneca kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of AstraZeneca from 9/9/2024 amounting to 0.776 USD, you needed to have the stock in your portfolio before the ex-date on 8/8/2024.
When did AstraZeneca pay the last dividend?
The last dividend was paid out on 9/9/2024.
What was the dividend of AstraZeneca in the year 2024?
In the year 2024, AstraZeneca distributed 2.346 USD as dividends.
In which currency does AstraZeneca pay out the dividend?
The dividends of AstraZeneca are distributed in USD.
Andere Kennzahlen von AstraZeneca
Our stock analysis for AstraZeneca Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AstraZeneca Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
